These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1465913)

  • 1. Late graft loss in cadaveric renal transplantation.
    Bergmann L; Roper L; Bow LM; Hull D; Bartus SA; Schweizer RT
    Transplant Proc; 1992 Dec; 24(6):2718-9. PubMed ID: 1465913
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular risk impact of cyclosporine immunosuppression in renal transplant recipients.
    Paul LC; Sutherland F; Klassen J; Buckle S; Burgess E
    Transplant Proc; 1992 Dec; 24(6):2740-1. PubMed ID: 1465922
    [No Abstract]   [Full Text] [Related]  

  • 3. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
    Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF
    Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
    [No Abstract]   [Full Text] [Related]  

  • 5. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract]   [Full Text] [Related]  

  • 6. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z; Adam K; Parapanissiou E; Sakellariou G; Papakyriazi E; Antoniadis A; Papadimitriou M
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of recipient and donor age on the outcome of renal transplantation.
    Rosman J; Steinhäuslin F; David S; Genton A; Mosimann F; Wauters JP
    Transplant Proc; 1992 Dec; 24(6):2723-4. PubMed ID: 1465916
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
    Park K; Kim YS; Kim SI
    Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulin A nephropathy in renal transplant recipients.
    Koselj M; Rott T
    Transplant Proc; 1992 Dec; 24(6):2762-4. PubMed ID: 1465932
    [No Abstract]   [Full Text] [Related]  

  • 12. Living-unrelated renal transplantation.
    Simforoosh N; Bassiri A; Amiransari B; Gol S
    Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
    [No Abstract]   [Full Text] [Related]  

  • 13. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
    Hiesse C; Rousseau P; Kriaa F; Larue JR; Charpentier B
    Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B; Ekberg H; Johnson U
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract]   [Full Text] [Related]  

  • 15. Kidney graft loss in children: implications for program development.
    Crocker JF; Wade AW; McDonald AT; McLellan DH; Lawen JG; Bitter-Suermann H; Acott PD
    CMAJ; 1998 Aug; 159(3):229-35. PubMed ID: 9724976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 17. A 20-year follow-up of cadaveric kidney allotransplantation.
    Candinas D; Keusch G; Conrad B; Schlumpf R; Decurtins M; Largiadèr F
    Transplant Proc; 1992 Dec; 24(6):2711-3. PubMed ID: 1465910
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
    Velidedeoğlu E; Tokyay R; Haberal M
    Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
    [No Abstract]   [Full Text] [Related]  

  • 19. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid withdrawal in renal transplant recipients.
    Ponticelli C; Tarantino A; Montagnino G
    Transplant Proc; 2001; 33(1-2):987-8. PubMed ID: 11267158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.